Introduction
ALS
ALS Centers
ALS Recovery Fund
ALS Support Groups
Directions
Campus Maps
Doctor's Corner
Drugs
Ilva Romano Fund
Kessenich Center
Links
How You Can Help
News
New Users
Quarterly Newsletter
Patient's Corner
Products & Services
Research
Translator

 
For site information, Email:Webmaster
 

The University of Miami ALS
Clinical and Research Program


Basic Research | Clinical Research | Stem Cell Research | HIV | New Studies
Symposium 1 | Symposium 2 | Symposium 2003 | Symposium 2004 | Symposium 2005
Respiratory Care in ALS | Orthotic Management for ALS
How to be an Effective Communication Partner | Summary


Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis, or Lou Gehrig's disease, is the most devastating neurodegenerative disease, affecting almost as many patients per year as multiple sclerosis. Patients become progressively paralyzed due to degeneration of the upper and lower motor neurons in the brain and spinal cord. They usually die within two to five years, unable to breathe or swallow. Each year University of Miami physicians care for more than 350 patients with ALS from the United States and other parts of the world. The School of Medicine is also the major center for pharmaceutical drug trials seeking new and effective treatments for the disease.

ALS is caused by a cascade of events, starting with genes that predispose the patient to develop the disease, triggered by some personal or environmental factor(s) that initiate degeneration of the motor neurons, and thereby induce spreading neuronal death. The processes leading to motor neuron degeneration include excess glutamate, oxidative and free radical damage, mitochondrial dysfunction, protein aggregation, and the activation of the cell death pathways. The Department of Neurology has basic research programs concentrating on genetics, mitochondrial abnormalities and protein aggregation in ALS. Funding received from the ALS Research Foundation, the ALS Recovery Foundation, the Muscular Dystrophy Association, the National Institutes of Health and other organizations support this research. Philanthropic gifts allow University scientists to concentrate on promising avenues of research.

Priority needs in the ALS Clinical and Research Program are:

  • The endowment of a professorship for ALS
$2 million
  • The endowment of a 5000 square foot research laboratory for ALS in the new science building of the medical school
$2 million
  • Research equipment for the new ALS Research Laboratory
$1 million
  • The endowment of research and clinical programs in ALS
$3 million
  • The endowment of a visiting scientist program, two scientists per year with research support
$1 million


This is an outline of some of the basic and clinical research that is being undertaken in the University of Miami ALS Clinical and Research Program designed to find the cause and cure of ALS.

 

   Copyright ©1997-2007 University of Miami, All Rights Reserved. 
   Terms of Use | Privacy Statement | Contact Us | Site Map
 Medical Disclaimer   
Web Technology